Lennart Mulder

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers

Esther H. Lips, Lennart Mulder, Anne M.M. Oonk et al. · British Journal of Cancer · 2013 · 238 citations · Full text

Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer

Petra ter Brugge, Petra Kristel, Eline van der Burg et al. · JNCI Journal of the National Cancer Institute · 2016 · 201 citations

Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response

Jorma J. de Ronde, Juliane Hannemann, Hans Halfwerk et al. · Breast Cancer Research and Treatment · 2009 · 168 citations · Full text

Surgical Oncology, Breast Oncology, Medicine +10

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response

Esther H. Lips, Lennart Mulder, Jorma J. de Ronde et al. · Breast Cancer Research and Treatment · 2013 · 114 citations · Full text

Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics

Esther H. Lips, Lennart Mulder, Jorma J. de Ronde et al. · Breast Cancer Research and Treatment · 2011 · 85 citations

Breast Oncology, Medicine, Immunology +10